Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Hypogonadism and erectile dysfunction: the role for testosterone therapy.

R Shabsigh1

  • 1Department of Urology, Columbia-Presbyterian Medical Center, New York 10032, USA. rs66@columbia.edu

International Journal of Impotence Research
|August 23, 2003
PubMed
Summary

Low testosterone

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The assessment of vascular risk in men with erectile dysfunction: the role of the cardiologist and general physician.

International journal of clinical practice·2013
Same author

Are men shortchanged on health? Perspective on life expectancy, morbidity, and mortality in men and women in the United States.

International journal of clinical practice·2010
Same author

Are men shortchanged on health? Perspective on health care utilization and health risk behavior in men and women in the United States.

International journal of clinical practice·2010
Same author

Sexual function in health and disease.

Postgraduate medicine·2009
Same author

Reliability of efficacy in men with erectile dysfunction treated with tadalafil once daily after initial success.

International journal of impotence research·2009
Same author

Daily patterns of sexual intercourse attempts by men with erectile dysfunction treated with tadalafil: influence of age and marital status.

International journal of impotence research·2009

Area of Science:

  • Urology
  • Endocrinology

Background:

  • Erectile dysfunction (ED) has multifactorial causes, including psychogenic and organic factors, with vasculogenic factors being most common.
  • Hormonal abnormalities, particularly low testosterone, are found in 10-20% of ED patients, but their precise role remains debated.
  • Erection physiology involves cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) pathways, targeted by various ED treatments.

Purpose of the Study:

  • To clarify the role of low testosterone in erectile dysfunction.
  • To review current diagnostic and therapeutic approaches for ED.
  • To explore the potential of combination therapies involving testosterone for ED.

Main Methods:

  • Review of existing literature on ED pathophysiology, diagnosis, and treatment.
  • Analysis of the physiological roles of testosterone and second messenger systems in erections.
  • Evaluation of current and emerging therapeutic strategies for ED.

Main Results:

  • Testosterone has direct effects on erectile tissue in animal models, but its impact on human penile function is less clear.
  • Common ED treatments include PDE5 inhibitors (e.g., sildenafil) and alprostadil, targeting cGMP and cAMP pathways, respectively.
  • Combination therapy with sildenafil and testosterone shows promise, suggesting potential for other combined treatment strategies.

Conclusions:

  • Correction of hypogonadism is an important initial step in managing ED.
  • Exploiting multiple physiological pathways, including those involving testosterone, may enhance ED treatment efficacy.
  • Further research into combination therapies holds potential for improved ED management.

Related Experiment Videos